Meta Pixel

News and Announcements

The Difference Between Crowdfunding Versus HNW Investors

  • Published December 20, 2022 1:21AM UTC
  • Publisher Leila Oliveira
  • Categories Capital Raising Tips

Crowdfunding vs HNW investors

Which one to choose?

I hear this question a lot, so here’s a quick summary 👇

– Crowdfunding: Investors are normally users of the product.

– HNW: do not only provide money. They are often successful entrepreneurs themselves, which means they are in the perfect position to give you advice.

– Crowdfunding: Check sizes around $1000

– HNW: Check sizes from $25K up to $250K

– Crowdfunding: It doesn’t have to be equity-based.

– HNW: You give away equity and have the investor with you in the long run.

In conclusion:

🎯 Go for crowdfunding if you have a working prototype and enough capital (or a large enough audience) to give your campaign the needed initial traction.

🎯 Go for HNW investors if you think you would benefit from mentorship and connections and if you have the right kind of scalable business to attract angels.

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now